The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial.

MJ Crawford, VC Leeson, R Evans, B Barrett, A McQuaid, J Cheshire, R Sanatinia, G Lamph, P Sen, K Anagnostakis, L Millard, I Qurashi, F Larkin, S Gibbon

Research output: Contribution to journalArticle (journal)peer-review

2 Citations (Scopus)
20 Downloads (Pure)

Abstract

Data from case series suggest that clozapine may benefit inpatients with borderline personality disorder (BPD), but randomised trials have not been conducted.
Original languageEnglish
JournalTherapeutic Advances in Psychopharmacology
Volume12
DOIs
Publication statusPublished - 29 Apr 2022

Fingerprint

Dive into the research topics of 'The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial.'. Together they form a unique fingerprint.

Cite this